Therapeutic factors in depression: New strategies;I fattori terapeutici nella depressione: Nuove strategie

Rivista di Psichiatria

Volumn 44, Issue 2, 2009, Pages 95-101

  Tomba, Elena ^a   Grandi, Silvana ^a   Fava, Giovanni A ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

Antidepressive agents; Depressive disorder; Psychotherapy; Self therapy

Indexed keywords

CLINICAL RESEARCH; CONVALESCENCE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMAN; MAJOR DEPRESSION; MOOD DISORDER; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; PUBLICATION; REMISSION; REVIEW; TREATMENT DURATION; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; DEPRESSION; HUMANS;

EID: 67449167859     PISSN: 00356484     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Fava GA: The concept of recovery in affective disorders. Psychotherapy and Psychosomatics, 1996,65,2-13.
2. Fava GA, Ruini C, Belaise C: The concept of recovery in major depression. Psychological Medicine, 2007,37,307-317.
3. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D, et al.: Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps. American Journal of Psychiatry, 2006,163,1905-1917.
4. Fava M, Evins AE, Dorer DJ, Schoenfeld DD: The problem of. the placebo response in clinical trials for psychiatric disorders. Psychotherapy and Psychosomatics. 2003,72,115-127.
5. Vieta E, Carne X: The use of placebo in clinical trials on bipolar: disorder. Psychotherapy and Psychosomatics, 2005,74,10-16.
6. Papakostas GI, Perlis RH, Seifert C, Fava M: Antidepressant dose reduction and the risk of relapse in major depressive disorder. Psychotherapy and Psychosomatics, 2007,76,266-270.
7. Nelson JC: The STAR*D study: a four course meal that leaves us wanting more. American Journal of Psychiatry, 2006, 163, 1864-1866.
8. Fava GA, Kellner R: Staging. A neglected dimension in psychiatric classification. Acta Psychiatrica Scandinavica, 1993,87,225- 230.
9. McGorry PD, Hichie IB, Yang AR, Pantelis C, Jackson HJ: Clinical staging of psychiatric disorders. The Australian and New Zealand Journal of Psychiatry, 2006,40,616-622.
10. Fava GA, Tossani E: Prodromal stage of major depression. Early Intervention in Psychiatry, 2007,1,9-18.
11. Boyce P, Judd F: The place for tricyclic antidepressants in the treatment of depression. The Australian and New Zealand Journal of Psychiatry, 1999,33,323-327.
12. Otto MW, Smits JAJ, Reese HE: Combined psychotherapy and pharmacotherapy for mood and anxiety disorders in adults: review and analyses. Clinical Psychology: Science and Practice, 2005,12,72-86.
13. Gaudiano BA, Miller IW, Hubert JD:The treatment of psychotic major depression: is there a role for adjunctive psychotherapy? Psychotherapy and Psychosomatics, 2007,271-277.
14. Fava GA, Ruini C, Rafanelli C: Psychometric theory is an obstacle to the progress of clinical research. Psychotherapy and Psychosomatics, 2004,73,145-148.
15. Fava GA: The intellectual crisis of psychiatric research. Psychotherapy and Psychosomatics, 2006,75,202-208.
16. Wise TN: Curiosity and crisis. Psychotherapy and Psychosomatics, 2006, 75,199-201.
17. Benazzi F: Suicidal ideation and depressive mixed states. Psychotherapy and Psychosomatics, 2005,74,61-62.
18. Benazzi F: Is there continuity between bipolar and depressive disorders? Psychotherapy and Psychosomatics, 2007,76,70-76.
19. Ghaemi SN, Baldessarini RJ: The manic-depressive spectrum and mood stabilization. Psychotherapy and Psychosomatics, 2007,76,65-69.
20. De Fruyt J, Demyttenaere K: Bipolar (spectrum) disorder and mood stabilization. Psychotherapy and Psychosomatics, 2007,76, 77-88.
21. Colom F, Vieta E: Sudden glory revisited: cognitive contents of hypomania. Psychotherapy and Psychosomatics, 2007, 76, 278- 288.
22. Fava GA: Do antidepressant and antianxiety drugs increase chronicity in affective disorders? Psychotherapy and Psychosomatics, 1994,61,125-131.
23. Baldessarini RJ: Risks and implications of interrupting maintenance psychotropic drugs therapy. Psychotherapy and Psychosomatics, 1995,63,137-141.
24. Fava GA: Can long-term treatment with antidepressant drugs worsen the course of depression? Journal of Clinical Psychiatry, 2003,64,123-133.
25. Editorial sparks debate on effects of psychoactive drugs. Psychiatric News, May 20,1994.
26. Posternak MA, Zimmerman M: Dual reuptake inhibitors incur lower rates of tachyphylaxis than selective serotonin reuptake inhibitors. Journal of Clinical Psychiatry, 2005,66,704-707.
27. Fava M, Rush AJ: Current states of augmentation and combination treatments for major depressive disorder. Psychotherapy and Psychosomatics, 2006,75,139-153.
28. Moncrieff J, Cohen D: Rethinking models of psychotropic drug action. Psychotherapy and Psychosomatics, 2005,74,145-153.
29. Fava GA, Park SK, Sonino N: Treatment of recurrent depression. Expert review of neurotherapeutics, 2006,6,1735-1740.
30. Fava GA, Sonino N: The clinical domains of psychosomatic medicine. Journal of Clinical Psychiatry, 2005,66,849-855.
31. Mokdad AH, Marks JS, Stroup DF, Gerberding JL: Actual causes of death in the United States, 2000. JAMA, 2004, 291,1238- 1245.
32. Andrews G: Should depression be managed as chronic disease? British Medical Journal, 2001,322,419-421.
33. Narayan KMV, Kanaya AM, Gregg EW: Lifestyles interventions for the prevention of type 2 diabetes mellitus. Treatments in endocrinology, 2003,2,315-320.
34. rd ed). Baltimore, Johns Hopkins University Press, 1991.
35. Fava GA: Cognitive-behavioral therapy. In: Fink M (ed). Encyclopedia of Stress. San Diego, CA, Academic Press, 2000.
36. Marks I, Dar R: Fear reduction by psychotherapies. British Journal of Psychiatry, 2000,176,507-511.
37. Marks IM: The maturing of therapy. British Journal of Psychiatry, 2002,180,200-204.
38. Fava GA, Rafanelli C, Grandi S, Conti S, Belluardo P: Prevention of recurrent depression with cognitive behavioral therapy. Archives of General Psychiatry, 1998,55,816-820.
39. Paykel ES, Scott J, Teasdale JD, Johnson AL, Garland A, Moore R, et al.: Prevention of relapse in residual depression by cognitive therapy. Archives of General Psychiatry, 1999,56,829-835.
40. Bockting CLH, Spinhoven P, Koeter MVT, Wounters LF, Schene AH: Differential predictors of response to preventive cognitive therapy in recurrent depression. Psychotherapy and Psychosomatics, 2006,75,229-236.
41. Kuehner C: An evaluation of the "Coping with depression course" for relapse prevention with unipolar depressed patients. Psychotherapy and Psychosomatics, 2005,74,254-259.
42. Fava GA, Rafanelli C, Cazzaro M, Conti S, Grandi S: Well-being therapy. Psychological Medicine, 1998,28,475-480.
43. Lau MA, McCain SF: Integrating mindfulness meditation with cognitive and behavioral therapies. Canadian Journal of Psychiatry, 2005,50,863-869.
44. Fava GA, Ruini C, Rafanelli C: Sequential treatment of mood and anxiety disorders. Journal of Clinical Psychiatry, 2005, 66, 1392-1400.
45. Blom MBJ, Jouver K, Dusseldorp E, Spinhoven P, Hoencamp E, Haffmans J, et al.: Combination treatment for acute depression is superior only when psychotherapy is added to medication. Psychotherapy and Psychosomatics, 2007,76,289-297.
46. Fava GA, Ruini C, Rafanelli C, Finos L, Conti S, Grandi S: Six-year outcome of cognitive behavioral therapy for prevention of recurrent depression. American Journal of Psychiatry, 2004,161, 1872-1876.
47. Zimmerman M, McGlinchey JB, Posternak MA, Friedman M, Attinlah N, Boerescu D: How should remission from depression be defined? American Journal of Psychiatry, 2006,163,148-150.
48. Ryff CD, Singer B: Psychological well-being. Psychotherapy and Psychosomatics, 1996,65,14-23.
49. Ryff CD, Dienberg-Love G, Urry HL, Muller D, Rosenkranz MA, Friedman EM, et al.: Psychological well-being and ill-being. Psychotherapy and Psychosomatics, 2006,75,85-95.
50. Pasquali R: The biological balance between psychological well- being and distress. Psychotherapy and Psychosomatics, 2006,75, 69-71.
51. Engel GL: A unified concept of health and disease. Perspectives in Biology and Medicine, 1960,3,459-485.
52. Fassone G,Trincia V, Pasquini M, Picardi A, D'Amato A, Biondi M, Pasquini P: Uno studio naturalistico di follow-up a 2 e 3.5 an- ni in pazienti con disturbi depressive unipolari. Rivista di Psichiatria, 2007,41,320-325.
53. Fava GA: A different medicine is possible. Psychotherapy and Psychosomatics, 2006,75,1-3.
54. Cosgrove L, Krimsky S, Vijayaraghavan M, Schneider L: Financial ties between DSM-IV panel members and the pharmaceutical industry. Psychotherapy and Psychosomatics, 2006, 75,154- 160.